Lecrolyn (Sodium Cromoglicate)

Sodium cromoglicate, the active ingredient in Lecrolyn, is a mast cell stabilizer presented as an ophthalmic solution for ocular use. It is employed to manage allergic conjunctivitis and seasonal ocular allergy by reducing histamine release in the eyes of affected patients.

GNH USA supplies Lecrolyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance across EU and other markets.

Lecrolyn, a mast cell stabilizer, is used to treat ocular allergic conditions by preventing mediator release.

Allergic conjunctivitis: reduces eye redness, itching and tearing caused by allergen exposure. Seasonal ocular allergy: alleviates symptoms during pollen seasons by stabilizing ocular mast cells. Mast cell‑mediated eye inflammation: helps control inflammation in various allergic eye disorders.

Lecrolyn may cause local ocular reactions.

Common Side Effects: - Transient eye irritation or burning sensation. - Stinging or mild discomfort upon instillation. - Blurred vision lasting a few minutes. - Mild conjunctival hyperemia. - Foreign body sensation. - Temporary increased tear production.

Serious or Rare Side Effects: - Allergic reaction with swelling of the eyelid or periorbital area. - Severe eye pain or photophobia. - Vision loss or sudden visual disturbance. - Corneal ulceration or epithelial defect. - Persistent redness unresponsive to treatment.

Before using Lecrolyn, consider the following precautions.

Assess patient history for active ocular infections: avoid use if infection is present. Avoid in patients with known hypersensitivity to sodium cromoglicate or formulation excipients. Do not wear contact lenses immediately after instillation unless advised by a clinician. Monitor for worsening symptoms: discontinue and seek medical advice if condition deteriorates. Store at room temperature: keep in the original container, protect from light and moisture.

Lecrolyn has a low potential for drug interactions, but certain combinations warrant attention.

Major Interactions (Avoid): - Concurrent use with ocular anesthetics may increase risk of corneal toxicity.

Moderate Interactions (Monitor Closely): - Topical corticosteroids may elevate intraocular pressure when used together. - Contact lens solutions can affect drug stability; verify compatibility. - Other ophthalmic antibiotics may cause additive ocular irritation. - Systemic antihistamines may reduce overall allergic response, potentially altering perceived efficacy.